BridgeMD
First-in-Human Study of RLY-4008 in Patients With ICC and Other Advanced Solid Tumors
EU CTIS ID: 2024-512622-29-00
What this study is testing
Part 1 To determine the MTD and RP2D of RLY-4008 To determine the safety and tolerability of RLY-4008 Part 2 and 3 To evaluate the efficacy of RLY-4008 by objective response rate (ORR) assessed by Independent Review Committee (IRC) Part 4 To assess the safety and tolerability of RLY-4008
- Phase I and Phase II (Integrated)- First administration to humans
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Main inclusion criteria for the study, including specific criteria for Part 1, 2, 3 and 4 can be found in the study protocol (section 5.2).
You likely can't join if
- Main exclusion criteria for the study, including specific criteria for Part 1, 2, 3 and 4 can be found in the study protocol (section 5.3).
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong
- United States
- United Kingdom
- Korea, Republic of
- Taiwan
- Singapore
- Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong; United States; United Kingdom; Korea, Republic of; Taiwan; Singapore and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.